| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.02 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |